Sihalalisela ngokufudumele uphiko lwethu lwemikhiqizo ye-Polypeptide ngokuphasisa ngempumelelo i-US FDA yokuhlola indawo "engenasici"!

Ukwedlula ukuhlolwa kwe-FDA endaweni "ngokungenasici" kuwumcimbi omkhulu emlandweni wethu wokuthuthukiswa kwe-cGMP. Akusho nje kuphela ukuthi i-API yethu ithole iphasiphothi yokungena emakethe yase-US, kodwa futhi ifakazela ukuthi ukuqaliswa kwe-cGMP enkampanini yethu kuye kwahambisana kancane kancane namazinga omhlaba.